Stock Ratings / Health Care / PLRZ / earnings

NSPR (38) PMI (61) RVP (33) MODD (36) ⌘ Pro Terminal →

Polyrizon Ltd. (PLRZ) Next Earnings Date & Expected ±12.5% Move

$9.00 +4.57% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Polyrizon Ltd. (PLRZ) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • SELL / AVOID Cap $21.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-7.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PLRZ)Realized 20D OHLCV Swing Band: ±12.5%

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$1.13 Expected Swing

MODEL EARNINGS SETUP GAUGE

PLRZ Quantitative Pre-Earnings Setup: 42/100

Trailing EPS: $4.25 • YoY Revenue Growth: 12.4%

Model Bullish Setup (42/100)Model Risk Weight (58/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$0	-$3.3M	-$4.5M	52%
FY 2024	2024-12-31	$0	-$1.5M	-$1.1M	52%
FY 2023	2023-12-31	$0	-$600.0K	-$537.0K	52%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PLRZ)

✓Walkthrough of PLRZ's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

PLRZ // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -43.40%▼ DESCENDING CHANNEL

2026-10-30O $9.46H $10.86L $9.00C $9.00VOL 45.9K

RES: $13.65SUP: $7.66SMA50: $10.53SMA200: $12.63

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PLRZ Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PLRZ Butterfly Map → + Track PLRZ →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PLRZ today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PLRZ. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PLRZ today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PLRZ)

Health Care Rank #590 of 1016 ⚔️ NSPR vs PLRZ Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PLRZ vs. NSPR, PMI, RVP, MODD)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Polyrizon Ltd. (PLRZ) ranks #590 by composite RQD confidence (42/100, grade D-) and #825 by equity capitalization ($21.9M). Within this direct 5-issuer industry benchmark cohort, PLRZ leads on earnings valuation at N/A trailing P/E, while RVP leads on capital efficiency and profitability with -23.3% ROIC and 0.1% gross margin. PMI currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with PLRZ at 42/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
PLRZ ACTIVE Polyrizon Ltd.	D-	42/100	—	—	-25.1%	+4.57%	$21.9M	Benchmark Subject
NSPR InspireMD Inc.	D-	38/100	—	29.5%	-35.0%	-3.55%	$21.0M	/nspr-vs-plrz →
PMI Picard Medical Inc.	C-	61/100	—	—	—	+12.17%	$19.9M	/pmi-vs-plrz →
RVP Retractable Technologies Inc.	E	33/100	—	0.1%	-23.3%	-1.15%	$17.3M	/rvp-vs-plrz →
MODD Modular Medical Inc.	D-	36/100	—	—	-35.0%	-9.95%	$16.3M	/modd-vs-plrz →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001893645

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Polyrizon Ltd. (PLRZ) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$3.3M, operating cash flow of -$4.5M, and free cash flow of -$4.5M (-295.4% YoY). On the balance sheet, PLRZ closed FY2025 with $21.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$0	-$3.3M	-$4.5M	-$4.5M	$21.4M	—
FY2024 (FY)	2024-12-31	$0	-$1.5M	-$1.1M	-$1.1M	$5.5M	—
FY2023 (FY)	2023-12-31	$0	-$600.0K	-$537.0K	-$537.0K	—	—

3. PLRZ Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PLRZ stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Polyrizon Ltd. (NASDAQ: PLRZ) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $9.00 (+4.57% 1D, market cap $21.9M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, PLRZ ranks #590 in composite RQD confidence.

How does PLRZ compare to NSPR and PMI in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), PLRZ carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -25.1%. By comparison, NSPR (InspireMD Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $21.0M) and PMI (Picard Medical Inc.) posts a C- grade (61/100 RQD, P/E N/A, ROIC —, cap $19.9M). Among the 5-stock peer group, PLRZ leads on earnings multiple (N/A) while RVP leads on capital efficiency (-23.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PLRZ?

Per PLRZ's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001893645), Polyrizon Ltd. generated $0 in revenue, -$3.3M in net income, and -$4.5M in free cash flow against $21.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PLRZ trading relative to its 50-day, 200-day, and 52-week technical levels?

PLRZ last traded at $9.00 (+4.57% on volume of 8,299 shares), positioning the stock -14.53% below its 50-day simple moving average ($10.53) and -28.74% below its 200-day simple moving average ($12.63). Across its 52-week range of $2.88 to $18.20, PLRZ sits at the 39.9% percentile with a 14-day RSI of 59.5 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($7.87 to $10.13).

PLRZ Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is PLRZ's next earnings date?

Based on SEC filing cadence, Polyrizon Ltd. (PLRZ)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is PLRZ stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for PLRZ, spanning a range between $7.87 and $10.13.

Direct Sub-Reports: PLRZ RQD Cockpit PLRZ 12M Forecast PLRZ Earnings & Move PLRZ Dividends & DRIP PLRZ Insiders & 13F PLRZ Whale Options PLRZ Profit Sankey PLRZ News & Why